Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical hold
Biotech
Neumora schizophrenia drug on FDA hold over rabbit convulsions
The FDA placed a phase 1 trial of Neumora’s NMRA-266 on hold after preclinical data revealed rabbits dosed with the drug had experienced convulsions.
James Waldron
Apr 15, 2024 9:00am
ProJenX ALS drug gets back on the map after partial FDA hold
Mar 29, 2024 10:44am
Innate drops monotherapy plans for lacutamab in type of lymphoma
Mar 21, 2024 8:27am
Nurix gets BTK degrader back on track after FDA lifts hold
Mar 11, 2024 9:25am
FDA lifts hold on Iovance's lung cancer cell therapy trial
Mar 4, 2024 9:44am
CytoDyn finally clears FDA hold on HIV program after 2 years
Feb 29, 2024 10:20am